Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Operating Expenses (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Operating Expenses data on record, last reported at $16.9 million in Q3 2025.

  • For Q3 2025, Operating Expenses rose 11.39% year-over-year to $16.9 million; the TTM value through Sep 2025 reached $66.3 million, up 4.31%, while the annual FY2024 figure was $61.0 million, 35.94% down from the prior year.
  • Operating Expenses reached $16.9 million in Q3 2025 per SNTI's latest filing, up from $16.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $44.2 million in Q3 2023 and bottomed at $1178.0 in Q1 2021.
  • Average Operating Expenses over 5 years is $15.5 million, with a median of $16.2 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: surged 1091750.59% in 2022, then plummeted 65.59% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $11.7 million in 2021, then soared by 44.31% to $16.9 million in 2022, then rose by 10.95% to $18.7 million in 2023, then decreased by 13.54% to $16.2 million in 2024, then grew by 4.83% to $16.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $16.9 million in Q3 2025, $16.8 million in Q2 2025, and $16.4 million in Q1 2025.